Sumitomo Acquires Shares Of C&O Pharmaceutical Of China For $73 Million
This article was originally published in PharmAsia News
Executive Summary
Japanese trading firm Sumitomo is entering the Chinese pharmaceutical market by acquiring a 29 percent stake of C&O Pharmaceutical Technology from Leo Star Development for SGD 96 million ($73.43 million)